Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Pharmacokinetics of tiotropium in asthmatic children aged 6-11 years support its safety profile.

Sharma A, Aalbers R, Hamelmann E, Goldstein S, Engel M, Moroni-Zentgraf P, Vogelberg C.

Pediatr Allergy Immunol. 2018 Nov;29(7):773-776. doi: 10.1111/pai.12952. Epub 2018 Sep 3. No abstract available.

PMID:
29972697
2.

Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma.

Aalbers R, Park HS.

Allergy Asthma Immunol Res. 2017 Sep;9(5):386-393. doi: 10.4168/aair.2017.9.5.386. Review.

3.

Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials.

Sharma A, Kerstjens HA, Aalbers R, Moroni-Zentgraf P, Weber B, Dahl R.

Pulm Pharmacol Ther. 2017 Feb;42:25-32. doi: 10.1016/j.pupt.2016.12.003. Epub 2016 Dec 28.

PMID:
28039077
4.

The asthma-COPD overlap syndrome: how is it defined and what are its clinical implications?

van den Berge M, Aalbers R.

J Asthma Allergy. 2016 Feb 10;9:27-35. doi: 10.2147/JAA.S78900. eCollection 2016.

5.

Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.

Aalbers R, Vogelmeier C, Kuna P.

Respir Med. 2016 Feb;111:1-7. doi: 10.1016/j.rmed.2015.11.002. Epub 2015 Nov 6. Review.

6.

Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease.

Aalbers R, Maleki-Yazdi MR, Hamilton A, Waitere-Wijker S, Zhao Y, Amatto VC, Schmidt O, Bjermer L.

Adv Ther. 2015 Sep;32(9):809-22. doi: 10.1007/s12325-015-0239-8. Epub 2015 Sep 24.

7.
8.

Temporal bone pneumatization in cystic fibrosis: a correlation with genotype?

Berkhout MC, van Rooden CJ, Aalbers RC, el Bouazzaoui LH, Fokkens WJ, Rijntjes E, Heijerman HG.

Laryngoscope. 2014 Jul;124(7):1682-6. doi: 10.1002/lary.24575. Epub 2014 Feb 6.

PMID:
24374715
9.

Single inhaler as maintenance and reliever therapy--is it SMART?

Aalbers R.

Lancet Respir Med. 2013 Mar;1(1):2-3. doi: 10.1016/S2213-2600(13)70020-1. Epub 2013 Mar 4. No abstract available.

PMID:
24321788
10.

Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.

Aalbers R, Brusselle G, McIver T, Grothe B, Bodzenta-Lukaszyk A.

Adv Ther. 2012 Nov;29(11):958-69. doi: 10.1007/s12325-012-0058-0. Epub 2012 Oct 17.

PMID:
23081745
13.

[Treatment of asthma during pregnancy].

Vroegop JS, Aalbers R, van Loon AJ.

Ned Tijdschr Geneeskd. 2009;153:B361. Review. Dutch.

PMID:
19785846
14.

Development of a questionnaire for the assessment of bronchial hyperresponsiveness.

Riemersma R, Postma D, Kerstjens H, Buijssen K, Boezen M, Aalbers R, Veldhuizen W, Strijbos J, van der Molen T.

Prim Care Respir J. 2009 Dec;18(4):287-93. doi: 10.4104/pcrj.2009.00026.

15.

Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.

de Heer P, Koudijs MM, van de Velde CJ, Aalbers RI, Tollenaar RA, Putter H, Morreau J, van de Water B, Kuppen PJ.

Eur J Surg Oncol. 2008 Nov;34(11):1253-61. doi: 10.1016/j.ejso.2008.05.003. Epub 2008 Jun 16.

PMID:
18556171
16.

Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO study.

Breekveldt-Postma NS, Erkens JA, Aalbers R, van de Ven MJ, Lammers JW, Herings RM.

Curr Med Res Opin. 2008 Apr;24(4):975-83. doi: 10.1185/030079908X280518 . Epub 2008 Feb 15.

PMID:
18282372
17.

Comparison and optimal use of fixed combinations in the management of COPD.

Mensing M, Aalbers R.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):107-16. Review.

18.

Caspase-3 activity predicts local recurrence in rectal cancer.

de Heer P, de Bruin EC, Klein-Kranenbarg E, Aalbers RI, Marijnen CA, Putter H, de Bont HJ, Nagelkerke JF, van Krieken JH, Verspaget HW, van de Velde CJ, Kuppen PJ; Dutch Colorectal Cancer Group.

Clin Cancer Res. 2007 Oct 1;13(19):5810-5.

19.

Onset of action of formoterol versus salmeterol.

Aalbers R, van der Woude HJ.

Respir Med. 2007 Apr;101(4):871-2; author reply 873-4. Epub 2007 Feb 12. No abstract available.

21.

Improved lung function and symptom control with formoterol on demand in asthma.

Cheung D, van Klink HC, Aalbers R; OZON study group.

Eur Respir J. 2006 Mar;27(3):504-10.

22.

[The treatment of asthma: indications for a change in approach].

Dekhuijzen PN, van Schayck CP, Wesseling G, Aalbers R, van Aalderen WM, Zaagsma J, van der Molen T.

Ned Tijdschr Geneeskd. 2006 Feb 4;150(5):237-41. Review. Dutch.

PMID:
16493987
23.

The relationship between self-efficacy and self-reported physical functioning in chronic obstructive pulmonary disease and chronic heart failure.

Arnold R, Ranchor AV, DeJongste MJ, Köeter GH, Ten Hacken NH, Aalbers R, Sanderman R.

Behav Med. 2005 Fall;31(3):107-15.

PMID:
16252622
24.

Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.

van der Woude HJ, Zaagsma J, Postma DS, Winter TH, van Hulst M, Aalbers R.

Chest. 2005 Mar;127(3):818-24.

PMID:
15764762
25.

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.

Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.

Curr Med Res Opin. 2004 Sep;20(9):1403-18.

PMID:
15383189
26.

Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.

van der Woude HJ, Postma DS, Politiek MJ, Winter TH, Aalbers R.

Respir Med. 2004 Sep;98(9):816-20.

27.

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.

van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.

Pulm Pharmacol Ther. 2004;17(2):89-95.

PMID:
15123230
28.

A systemic antitumor immune response prevents outgrowth of lung tumors after i.v. rechallenge but is not able to prevent growth of experimental liver tumors.

van Duijnhoven FH, Aalbers RI, Rothbarth J, Terpstra OT, Kuppen PJ.

Clin Exp Metastasis. 2004;21(1):13-8.

PMID:
15065598
29.

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.

Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.

Curr Med Res Opin. 2004;20(2):225-40.

PMID:
15006018
30.

Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.

van der Woude HJ, Aalbers R.

Am J Respir Med. 2002;1(1):55-74. Review.

PMID:
14720076
31.

Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis.

Velthuis JH, Stitzinger M, Aalbers RI, de Bont HJ, Mulder GJ, Kuppen PJ, Nagelkerke JF.

Clin Exp Metastasis. 2003;20(8):713-21.

PMID:
14713105
32.

A 71-yr-old male with increasing dyspnoea, cough and an intrathoracic mass.

Seebus E, Vrugt B, de Jong RS, Aalbers R.

Eur Respir J. 2003 Dec;22(6):1042-5. No abstract available.

33.

Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer.

van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ.

Photochem Photobiol. 2003 Sep;78(3):235-40.

PMID:
14556309
34.

Neurofibromatosis type I and pregnancy: a fatal attraction? Development of malignant schwannoma during pregnancy in a patient with neurofibromatosis type I.

Posma E, Aalbers R, Kurniawan YS, van Essen AJ, Peeters PM, van Loon AJ.

BJOG. 2003 May;110(5):530-2. No abstract available.

35.

The immunological consequences of photodynamic treatment of cancer, a literature review.

van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ.

Immunobiology. 2003;207(2):105-13. Review.

PMID:
12675268
36.

The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma.

Hamilton LM, Torres-Lozano C, Puddicombe SM, Richter A, Kimber I, Dearman RJ, Vrugt B, Aalbers R, Holgate ST, Djukanović R, Wilson SJ, Davies DE.

Clin Exp Allergy. 2003 Feb;33(2):233-40.

PMID:
12580917
37.

A tumor-specific kinase activity regulates the viral death protein Apoptin.

Rohn JL, Zhang YH, Aalbers RI, Otto N, Den Hertog J, Henriquez NV, Van De Velde CJ, Kuppen PJ, Mumberg D, Donner P, Noteborn MH.

J Biol Chem. 2002 Dec 27;277(52):50820-7. Epub 2002 Oct 21.

38.

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.

Aalbers R, Ayres J, Backer V, Decramer M, Lier PA, Magyar P, Malolepszy J, Ruffin R, Sybrecht GW.

Eur Respir J. 2002 May;19(5):936-43. Erratum in: Eur Respir J 2002 Jul;20(1):245.

39.

Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.

van der Woude HJ, Aalbers R.

Eur Respir J. 2001 Aug;18(2):269-71.

41.
42.

A 49-year-old woman with well-differentiated fetal adenocarcinoma.

Politiek MJ, Vrugt B, Aalbers R.

Neth J Med. 2001 Apr;58(4):177-80.

PMID:
11325495
43.

Short-term budesonide dosage.

van Der Woude HJ, Aalbers R.

Chest. 2001 Jan;119(1):309-10. No abstract available.

PMID:
11157626
44.

Bronchial angiogenesis in severe glucocorticoid-dependent asthma.

Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R.

Eur Respir J. 2000 Jun;15(6):1014-21.

45.
46.

A man with upper respiratory tract infections, general weakness and fever.

Berge MV, Snoek WJ, Nijboer EW, Julius AJ, Aalbers R.

Eur Respir J. 1999 Aug;14(2):469-70. No abstract available.

47.

Mucosal inflammation in severe glucocorticoid-dependent asthma.

Vrugt B, Wilson S, Underwood J, Bron A, de Bruyn R, Bradding P, Holgate ST, Djukanovic R, Aalbers R.

Eur Respir J. 1999 Jun;13(6):1245-52.

48.
49.

Safety of biopsies and bronchoalveolar lavage.

Djukanović R, Dahl R, Jarjour N, Aalbers R.

Eur Respir J Suppl. 1998 Mar;26:39S-41S. Review. No abstract available.

PMID:
9585880
50.

Bronchoalveolar lavage: performance, sampling procedure, processing and assessment.

Rennard SI, Aalbers R, Bleecker E, Klech H, Rosenwasser L, Olivieri D, Sibille Y.

Eur Respir J Suppl. 1998 Mar;26:13S-15S. Review. No abstract available.

PMID:
9585873

Supplemental Content

Loading ...
Support Center